Opinion
Biotech pipeline hosts 163 potential meds for mental illness, with depression dominating: PhRMA
.jpg?VersionId=wFv3FPgwxu3MDp.qHxMIyEh9VBBuKNgu)
There are currently 163 medicines targeting mental illness being assessed in clinical trials or awaiting FDA review, according to PhRMA.
There are currently 163 medicines targeting mental illness being assessed in clinical trials or awaiting FDA review, according to PhRMA.
